Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

ertugliflozin-metFORMIN

ertugliflozin-metFORMIN
  • Non-formulary
  • Therapeutic Interchange
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Segluromet TABLET, ORAL 2.5 mg-500 mg, 2.5 mg-1,000 mg, 7.5 mg-500 mg, 7.5 mg-1,000 mg    
Comments:
 
Segluromet medication guide
Ordered Formulation Therapeutic Interchnage

ertugflozin-metFORMIN (Segluromet)                                                   

  • 2.5 mg-500 mg BID                                                                 
  • 2.5 mg-1,000 mg BID                                                            
  • 7.5 mg-500 mg BID                                                     
  • 7.5 mg-1,000 mg BID                                                                      

ertugliflozin (Steglatro) and metFORMIN (Glucophage)

  • ONE 5 mg ertugliflozin ONCE daily PLUS 500 mg metFORMIN BID
  • ONE 5 mg ertugliflozin ONCE daily PLUS 1,000 mg metFORMIN BID
  • ONE 15 mg ertugliflozin ONCE daily PLUS 500 mg metFORMIN BID
  • ONE 15 mg ertugliflozin ONCE daily PLUS 1,000 mg metFORMIN BID

Reviewed: 18 Dec 18 (Segluromet)

 
Last updated: Dec. 20, 2018






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved